Cargando…
Muscle and serum myostatin expression in type 1 diabetes
Type 1 diabetes (T1D) has been reported to negatively affect the health of skeletal muscle, though the underlying mechanisms are unknown. Myostatin, a myokine whose increased expression is associated with muscle‐wasting diseases, has not been reported in humans with T1D but has been demonstrated to...
Autores principales: | Dial, Athan G., Monaco, Cynthia M. F., Grafham, Grace K., Romanova, Nadya, Simpson, Jeremy A., Tarnopolsky, Mark A., Perry, Christopher G. R., Kalaitzoglou, Evangelia, Hawke, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354085/ https://www.ncbi.nlm.nih.gov/pubmed/32652899 http://dx.doi.org/10.14814/phy2.14500 |
Ejemplares similares
-
3152 The role of myostatin in diabetic bone disease
por: Kalaitzoglou, Evangelia, et al.
Publicado: (2019) -
Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin‐Deficient Diabetic Mice
por: Bunn, R Clay, et al.
Publicado: (2023) -
Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes
por: Travis, Callie, et al.
Publicado: (2022) -
Myostatin in the Pathophysiology of Skeletal Muscle
por: Carnac, Gilles, et al.
Publicado: (2007) -
Significance of serum Myostatin in hemodialysis patients
por: Esposito, Pasquale, et al.
Publicado: (2019)